Commonwealth Equity Services, LLC Genocea Biosciences, Inc. Transaction History

Commonwealth Equity Services, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.01 - $1.38 $400 - $55,295	-40,069 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$0.96 - $1.35 $7,764 - $10,918	8,088 Added 25.29%	40,069 $50,000
Q4 2021 Jan 31, 2022	BUY	$0.95 - $1.99 $10,047 - $21,046	10,576 Added 49.41%	31,981 $37,000
Q3 2021 Oct 29, 2021	BUY	$1.74 - $2.33 $1,218 - $1,631	700 Added 3.38%	21,405 $41,000
Q1 2021 May 04, 2021	BUY	$2.35 - $4.01 $6,542 - $11,163	2,784 Added 15.53%	20,705 $56,000
Q4 2020 Feb 11, 2021	BUY	$1.91 - $2.67 $7,449 - $10,413	3,900 Added 27.82%	17,921 $43,000
Q3 2020 Nov 05, 2020	BUY	$1.81 - $5.53 $74 - $226	41 Added 0.29%	14,021 $32,000
Q1 2020 May 11, 2020	BUY	$1.26 - $2.73 $17,614 - $38,165	13,980 New	13,980 $24,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.